StonvexLoading…
StonvexStonvexStonvexCore line items from CMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.67B | $8.30B | $6.17B | $4.20B |
Operating Income | $490.00M | $1.73B | $1.29B | $811.00M |
Net Income | $340.00M | $1.07B | $782.00M | $505.00M |
EPS (Diluted) | $1.10 | $3.53 | $2.59 | $1.67 |
Total Assets | $40.28B | $39.94B | $38.01B | $37.70B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $175.00M | $509.00M | $362.00M | $844.00M |
Free Cash Flow OCF − CapEx | $-334.00M | Not available | $-993.00M | $-358.00M |
Shares Outstanding | 308.90M | 306.40M | 304.30M | 299.30M |